Annexon director Mark Blumenkranz files Form 3
Annexon, Inc. director Mark S. Blumenkranz filed an initial statement of beneficial ownership on Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Annexon, Inc. director Mark S. Blumenkranz filed an initial statement of beneficial ownership on Form 3. The filing identifies him as a director of Annexon but reports no transactions and no reportable holdings or derivative positions at this time. An Exhibit 24 power of attorney is referenced.
Key Terms
Form 3 regulatory
beneficial ownership financial
Power of Attorney regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Annexon (ANNX) Form 3 filed by Mark S. Blumenkranz disclose?
Does the Annexon (ANNX) Form 3 show any stock transactions by Mark S. Blumenkranz?
What role does Mark S. Blumenkranz have at Annexon (ANNX) according to the Form 3?
What is the Exhibit 24 mentioned in the Annexon (ANNX) Form 3 remarks?
AI-generated analysis. How Rhea-AI works. Not financial advice.